MacroGenics, Inc., a biopharmaceutical company focused on developing and commercializing innovative antibody-based therapeutics for the treatment of cancer, announced that it has promoted Eric Risser to Chief Operating Officer, as of February 22.
February 28, 2022
· 4 min read